Patients may catch infections during they are in the hospital, the hospital acquired infection test is used to diagnose those infections.
The industry is anticipated to witness a significant growth in the next few years. One of the key factors driving industry growth is the rising geriatric population base. Advancing age of the geriatric population makes them more vulnerable and prone to diseases, thus increasing the demand for diagnosis.

Market Analysis and Insights: Global Hospital Acquired Infections (HAI) Diagnostics Market
The global Hospital Acquired Infections (HAI) Diagnostics market size is projected to reach US$ 4474.4 million by 2027, from US$ 3331.9 million in 2020, at a CAGR of 4.3% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hospital Acquired Infections (HAI) Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hospital Acquired Infections (HAI) Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hospital Acquired Infections (HAI) Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hospital Acquired Infections (HAI) Diagnostics market.

Global Hospital Acquired Infections (HAI) Diagnostics Scope and Market Size
Hospital Acquired Infections (HAI) Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hospital Acquired Infections (HAI) Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Molecular Diagnostics Tests
Other In-vitro Diagnostic Tests

Segment by Application
Bloodstream Infections (BSI)
Urinary Tract Infections (UTI)
Surgical Site Infections (SSI)
Pneumonia
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
BioMérieux
Abbott Laboratories
Roche AG
Siemens Healthcare